This import risk analysis examines the biosecurity risks associated with the international trade in non-viable crustaceans of freshwater or marine origin that are intended for human consumption. Crustaceans that are cultured or wild-caught for human consumption mainly belong to the order Decapoda (shrimps or prawns, lobsters and crabs) and to a lesser extent the order Euphausiacea (krill) and the order Stomatopoda (mantis shrimps). They may be imported into New Zealand chilled, frozen or processed.
This document is a qualitative analysis of the risk posed by Mycoplasma bovis (M. bovis) in bovine in-vivo derived and in-vitro produced embryos.
This risk analysis considers the biosecurity risks associated with the importation of captive hatched and reared, saltwater and freshwater Crocodilia from the European Union (for the purposes of this document referred to as the European Zone), and Malaysia, Singapore, Indonesia, Thailand, Papua New Guinea and northern Australia (collectively referred to as the ‘Malaysian Zone’).
This document is a qualitative analysis of the risk posed by bovine leukaemia virus (BLV), the causative agent of Enzootic bovine leukosis (EBL) and Campylobacter fetus subspecies venerealis (Cfv), the causative agent of bovine genital campylobacteriosis (BGC), in imported frozen bovine semen and in-vivo derived and in-vitro produced embryos.
This qualitative risk analysis examines the biosecurity risks associated with the importation of bee products derived from honey bees (Apis mellifera). These risks were previously examined in 2004 (MAF 2004). However, recognising technical advances, reports of newly identified pathogens of honey bees and changes to the OIE Terrestrial Animal Health Code over the intervening 11 year period, a supplementary biosecurity import risk analysis has been requested.
This risk analysis has been developed in order to support the Australasian Species Management Programmes managed by the Australasian Regional Association of Zoological Parks and Aquaria (ARAZPA) members in New Zealand. Captive breeding within Australasia has been successful, and in order to sustainably manage the population it is necessary to transfer animals between Australia and New Zealand. This will enable genetic diversity to be maintained, birth/sex ratios and social structures to be managed; and therefore ensure that the breeding programmes can successfully continue.
This document:
• Estimates the level of efficacy required for a treatment for BMSB on any given pathway based on the propagule pressure from BMSB and the likely volume of imports;
• Describes the level of efficacy provided by published or reported treatment research;
• Provides information to enable lab-determined treatment schedules to be converted into operational schedules;
• Provides background/references on the effect of the treatments on other pests to illustrate relativity to BMSB.
A total of 187 different species or pest/disease complexes were identified from a literature review for phytosanitary-related organisms potentially associated with imported Phase 3 Agaricus bisporus mushroom compost from northern Europe.
Rapid Risk Assessment: Pasteurised eggs: Addendum to 2008 Import Risk Analysis
A request was received from Indonesia to allow the importation of fresh salacca fruit into New Zealand. A risk analysis had already been completed by the Australian Department of Agriculture (DoA) for the importation of salacca fruit from Indonesia to Australia. This was used as a starting point for the New Zealand risk analysis. Three genera of mealybugs and two species of fungi were found to be non-negligible risks to New Zealand from this pathway, so additional measures may be warranted.